Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Cumulative latent virus, rare disease & other by Year
Cumulative latent virus, rare disease & other therapeutic trials (trials)
Moderna Cumulative latent virus, rare disease & other: 41.00 trials in FY2025, up 7.9% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cumulative latent virus, rare disease & other therapeutic trials (trials) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41.00 | +7.9% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2024 | Dec 31, 2024 | 38.00 | +18.8% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2023 | Dec 31, 2023 | 32.00 | +33.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2022 | Dec 31, 2022 | 24.00 | +33.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2021 | Dec 31, 2021 | 18.00 | +157.1% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2020 | Dec 31, 2020 | 7.00 | +16.7% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2019 | Dec 31, 2019 | 6.00 | +100.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2018 | Dec 31, 2018 | 3.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
Cite this data
StockData. (2026). Moderna Cumulative latent virus, rare disease & other, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-latent-other
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.